Why We Prioritize a Strong Ethical Position 

The burgeoning psychedelic field brings particular ethical considerations from–social justice and inclusion–to data use and privacy. We are committed to being a community leader in both the equal access to psychedelic medicine and the ethical flow of data. We are grateful for the opportunity to identify and operationalize our ethical commitments into every aspect of our company. 

At Maya, we know that psychedelic medicine has the power to shift the paradigm of mental healthcare on a global scale. However, the pioneers in psychedelic medicine don’t have an easy way to to demonstrate the clinical benefits of their work. Maya is a software platform designed to help psychedelic practitioners manage, measure, and illustrate health outcomes, so they can optimize services, scale safely, and help advance psychedelic healthcare.

While we know that Maya will play a key role in generating essential insights into psychedelic therapy practices, we also acknowledge that this role comes with great responsibility. We take our role as the ethical stewards of the flow of data between patients, clients, practitioners and researchers very seriously. The following ethical positions will serve as the foundation for everything that we do and everything we stand for. We’re humbled at the collective knowledge of the psychedelic community and grateful for the opportunity to continue working on these values as our field evolves.

-David Champion, CEO and Co-Founder 

Maya's Ethical Commitments

Purpose Over Profit

  • We are a Public Benefit Corporation (PBC) which means our team members, advisors, investors, and  supporters are aligned to prioritize purpose and not just profit. We are laying the foundations of a global environment for psychedelic healthcare to scale safely and effectively.
  • We are committed to ethically-aligned investment which means all of our investors are required to sign our Investor Covenant.
Read Our Investor Covenant

Responsible Data Stewardship

  • We adhere to the best practices set out by
  • We give you control over your health information.
  • We want you to decide how your information is used and with whom it is shared.
  • We will not sell or lease your individual-level information to any third party without your explicit consent.
  • We will ensure that your individual-level information is restricted from unauthorized access or export.
  • All Maya user data is secured with AES (Advanced Encryption Standard) 256-bit SSL end-to-end encryption. 
  • Any and all PHI (Patient Health Information) is protected and secured in accordance with HIPAA (The Health Insurance Portability and Accountability Act).
  • Patients have the authority to retract their date from the system at will.
  • If you opt in and consent to participate in our research, your de-identified data will be used to contribute to research at Maya PBC or third-party institutions working with Maya PBC. Consenting allows our researchers and approved third-party researchers to use a customer's de-identified data in aggregate for a variety of studies.
  • We will not use your data to market to you or sell you products, without your explicit consent via opt-in.
Read Our Statement on Data and Privacy

Acknowledging Risks

  • Greatest technology risk: A breach in our security exposing patient health information. We are mitigating this by investing in third party security consultants as well as database design consultants, healthcare compliance consultants, and third party audits. Our unit testing now provides 95% code coverage to automatically expose any such vulnerabilities. We also have zero-trust security policies mandating strict verification of any connection to the systems both inside and outside of the organization. We conduct audits of all reads and writes of PHI to the database. We have integrated quality assurance processes incorporating security gates to identify and reduce vulnerabilities in code prior to release.
  • Greatest market risk: An incumbent digital therapeutics company with pre-existing technology may enter the sector. We are mitigating this by focusing on brand and community. The psychedelic community is extremely protective and mission-driven, and has already been vocal of its support for Maya’s values-aligned stance. We are building a data moat composed of psychedelic treatment specific protocols and health outcomes data that will continuously differentiate Maya’s value.
  • Greatest execution risk: Expanding to different audience segments may pull our product priorities in divergent directions. Currently we believe the private practitioners, clinicians, retreat leaders, life science researchers, and academic researchers all need the same platform to perform research programs. However, their needs differ and we are mitigating this risk by focusing on functionality that serves all segments, while working with smaller cohorts across each.
  • Greatest regulatory risk: If there are too many cases of mishandled psychedelic treatments resulting in harmful outcomes, the positive momentum towards federal legalization could be reversed by negative press and legislator fear. We are mitigating this risk by preparing our platform and server architecture for a global rollout. We believe firmly that no matter the decisions of one country, psychedelic treatments will be legalized for their merit at-large.

Listening to the Community

  • We are signatories on the North Star Psychedelic Ethics Pledge. The North Star Pledge is an opportunity for companies in the psychedelic space to consider seven key commitments and make them their own.
Read the North Star Ethic Pledge
  • We encourage community engagement through our Council of Guides. Every element of Maya, from our software platform to our business model, is developed in collaboration with psychedelic practitioners, educators, and researchers.
Learn About Our Council of Guides
  • We highlight a diverse collection of luminaries on our Psychedelic Therapy Podcast. The podcast is a weekly conversation series with leaders in the psychedelic community specifically for therapists, healers, retreat leaders, and passionate enthusiasts.
Listen to The Psychedelic Therapy Podcast

Giving Back and Supporting Equal Access to Psychedelic Healthcare

  • We will offer discounted software to practitioners, healers, guides, and clinicians who have equal access programs for underserved clients and those who would not otherwise be able to access the platform.
  • We will offer non-commercial usage licenses for researchers in an effort to accelerate psychedelic research through access to anonymized aggregated data.
  • We will sponsor online learning opportunities for practitioners operating in underserved communities.
  • We will give away a percentage of our profits, with a preference to supporting non profit organizations that are aligned with our mission.

North Star Pledge from the Auryn Project

We are grateful for the leadership of the Auryn Project and their dedication to creating a framework for businesses like ours to follow. The North Star Pledge is an opportunity for companies in the psychedelic space to consider seven key commitments and make them their own. We have taken our time with this pledge, to truly work it into our business model and all of our company practices.